Immunization Competencies. For BC Health Professionals

Similar documents
British Columbia Data Standards

Public Health Nurse Orientation Services to Prevent and Control Communicable Disease. Learning Objectives. Section II: Immunizations

SECTION 11 IMMUNIZATION WORK PLANS

Hepatitis B Immune Globulin Biological Page

Vaccinating Adults: A Step-by-Step Guide

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Opinion. Vaccination Programmes and Health Systems in the EU. Expert Panel on Effective Ways of Investing in Health

Immunization with Influenza Vaccine (Inf)

Health Care Worker Vaccinations, 2011: EXTENDED CARE FACILITIES

Pneumococcal 13-valent Conjugate Vaccine Biological Page

Newfoundland and Labrador Pharmacy Board Standards of Practice

Administering Injections and Immunizations Preparation Course

How new vaccines are introduced into programs & why programs differ across Canada

Disclosure Statement. I have no affiliation (financial or otherwise) with a pharmaceutical, medical device or communications organization.

Monitoring Vaccines Introduction. Pia Caduff-Janosa MD May 2013

Practice Direction Standard of Practice # 5: Administration of Drugs including Vaccines

Seasonal Influenza Peer Vaccination Programme Immunisation Process

Tetanus Immune Globulin (Human) Biological Page

Grade 8 Immunization Package

Review of Controlled Drugs and Substances Act

Vaccine Administration. Practice Nurse Gillian Healy RGN, RM, BSc, Clinical Nurse Specialist in Practice Nursing

Influenza. Influenza vaccines (WHO position paper) Weekly Epid. Record (2005, 80: ) 287

8. Public Health Measures

Polio Vaccine Biological Page

Immunization of Adults in High Risk Populations. Carol A. Kurbis MD, CCFP, FRCPC WRHA Medical Officer of Health

A guide to peer support programs on post-secondary campuses

Hepatitis B Vaccine: ENGERIX -B

Vaccine Administration An Evidence Based Approach

SUMMARY OF PRODUCT CHARACTRISTICS

1 INFLUENZA IMMUNIZATION IN YORK REGION: RATES OF UPTAKE AMONG HEALTH CARE WORKERS IN HOSPITALS AND LONG-TERM CARE HOMES

Gaps in Influenza Clinical Research. Presented by: Dr Gina Samaan Technical Officer, Indonesia Field Epidemiology Training Program

The National Vaccine Advisory Committee: Reducing Patient and Provider Barriers to Maternal Immunizations

The pages that follow contain information critical to protecting the health of your patients and the citizens of Colorado.

Improving Immunization Rates

MedInform. Ethical and healthcare considerations in relation to mandatory vaccination - Bulgarian perspective. Literature Review

Vaccination-Strategies

Pandemic Influenza Planning Considerations in On-reserve First Nations Communities

Meningococcal Conjugate (Groups A, C, Y and W-135) Vaccine Biological Page

Immunity and how vaccines work

2007 ACIP Recommendations for Influenza Vaccine. Anthony Fiore, MD, MPH Influenza Division, NCIRD, CDC

Please read Chapters 5, 6 and 7 of your vaccine text for next Wednesday s lecture. Chapters 9, 17 and 8 for next Friday s lectures

Varicella (Chickenpox) and Varicella Vaccines

Definition of Standing Order

Vaccine Safety Monitoring for ph1n pandemic vaccine:

APEC Guidelines Immunizations

Hepatitis B Vaccine Biological Page

Immunity & How Vaccines Work

Role of the Pharmacist in the Provision of Immunization Services

H1N1 pandemic. Model Training for National Adaptation

BOOSTRIX -POLIO: Diphtheria-Tetanus- Acellular Pertussis-Polio Combined Vaccine Biological Page (dtap-ipv)

ADMINISTERING VACCINATIONS AT OFFSITE LOCATIONS

Vaccination 101. Mary Conant-Cantor BSN, RN Nurse Manager Massachusetts Dept Of Public Health Immunization Program

H1N Influenza Q & A With a Focus on Panvax

How do I comply with the Influenza Control Program Policy this year?

2013 British Columbia/Washington State Cross Border Infectious Disease/Pandemic Tabletop Exercise

RE: CONSULTATION ON DRAFT - DRUG AND NATURAL HEALTH PRODUCTS RECALL GUIDE

Deployment of Combination Vaccines and STI vaccines

SEASONAL INFLUENZA VACCINE INFORMATION FOR IMMUNIZATION PROVIDERS

Northwestern Health Unit

DECISION SUPPORT TOOL FOR RN SANES DISPENSING PROPHYLAXIS FOR SEXUALLY TRANSMITTED INFECTION AFTER SEXUAL ASSAULT

NHS public health functions agreement Service specification No.32 Human papillomavirus immunisation programme for men who have sex with men

Introduction to Immunisations & Cold Chain Management in General Practice. April 2016

Diphtheria-Tetanus-Acellular Pertussis-Polio- Haemophilus influenzae type b Conjugate Combined Vaccine Biological Page (DTaP-IPV-Hib)

The Federal Initiative To Address HIV/AIDS in Canada. Canada s Domestic Response to HIV/AIDS

Routine Immunization Products

Canadian Health Care Systems

9/11/2018. Polio and Polio Vaccine. Poliomyelitis Disease. Poliovirus. First outbreak described in the U.S. in 1843

UPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES

Expedited procedure for evaluating pandemic influenza A (H1N1) 2009 vaccines

COMPUS Vol 2, Issue 8 December 2008

Session 2 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER

Manitoba Annual Immunization Surveillance Report

How do I comply with the Influenza Prevention Policy this year?

Table of Contents. 1.0 INFANRIX hexa VACCINE...3

Foundations of Personal Wellness - EL2082

Influenza Vaccine Questions and Answers. Influenza Control Program

HPV Immunization, Canadian Perspective

O N E R O O T, M A N Y R O U T E S Impact of User-Based System Design on Immunization Delivery

ANNUAL INFLUENZA IMMUNIZATION POLICY

H1N Influenza Virus Q & As

Using a Café to Demystify Recommendations, Engage Audiences, and Address Barriers

Rotavirus Vaccine Program in British Columbia Information for Health Care Providers Date of Issue: February 2012

Vaccines. Vaccines ( continued 1) February 21, 2017 Department of Public Health Sciences

Immunization Manual Interlake Regional Health Authority Public Health Program. January 2012

Flu vaccination service All you need to know to make a success of the new service. Alastair Buxton Leyla Hannbeck Fin Mc Caul

How do I comply with the Influenza Control Program Policy this year?

Pneumococcal Vaccines. What s right for your clients?

Infection Control Manual Residential Care Part 2 Infection Control Program Guidelines IC3: CCHSA Standards

Gene Vaccine Dr. Sina Soleimani

HIV/AIDS. Saskatchewan. Saskatchewan Health Population Health Branch

Guideline scope Smoking cessation interventions and services

TELL ME Communication Kit

Diphtheria-Tetanus-Acellular Pertussis-Polio- Combined Vaccine Biological Page (DTaP-IPV)

Immunization and Vaccines

Routine Immunization Products

BC First Nations Panorama Implementation Project (FN PIP) WE WOULD LIKE TO HEAR FROM YOU!

IMMUNIZATION IN CHILDREN WITH CANCER

Pandemic Influenza Preparedness and Response

Transcription:

Immunization Competencies For BC Health Professionals September 2010

Preamble The competencies contained in the Immunization Competencies for BC Health Professionals were developed from the Immunization Competencies for Health Professionals, Public Health Agency of Canada (http://www.phac-aspc.gc.ca/im/pdf/ichp-cipseng.pdf ). The competencies and learning objectives were adapted to the BC context. The competencies range from knowledge of the scientific basis of immunization to essential immunization practices and contextual issues relevant to immunization. Each competency is supported by a number of guiding learning objectives and key terms. This document does not dictate how to teach or assess health professionals. Instead, it lays out the essential topics for effective immunization that are universal to a wide range of health professionals. These can be adapted and incorporated into all immunization training or performance evaluations. As such, the immunization competencies proved the framework stakeholders can use to tailor education programs to the needs of health professionals based on their level of experience, practice setting, and degree of involvement with immunization. September 2010

Table of Contents 1. Vaccine Preventable Diseases... 1 2. The Immune System... 2 3. Vaccine Development and Evaluation... 3 4. Immunizing Agents... 4 5. Vaccine Immune Response... 5 6. Immunization Schedules... 6 7. Populations Requiring Special Considerations... 7 8. Storage and Handling of Immunizing Agents... 8 9. Administration of Immunizing Agents... 9 10. Reactions Following Immunization... 10 11. Documentation... 11 12. Legal and Ethical Aspects of Immunization... 12 13. Population Health... 13 14. Communication: Part 1 - Principles... 14 15. Communication: Part 2 - Immunization Issues... 15 16. The Canadian Immunization System... 16 September 2010

1. Vaccine Preventable Diseases Demonstrates an understanding of the rationale and benefit of immunization. 1. Describe the historical impact of immunization on the epidemiology of vaccinepreventable disease. 2. Response to the question Why should I be immunized when vaccine preventable diseases are so rare in Canada? 3. Describe the key clinical features, including acute and long term complications, of each vaccine-preventable disease. 4. Describe the key epidemiologic features of each vaccine-preventable disease. Clinical features, communicability, complications, incubation period, transmissibility, vaccine-preventable diseases. September 2010 1

2. The Immune System Demonstrates a general understanding of the immune system. 1. Compare and contrast innate and adaptive immunity. 2. Differentiate between passive and active immunity. 3. Describe the lymphatic system 4. Describe the development of the fetal and infant immune system. Active immunity, antibody, antigen, B-lymphocyte (B-cell), cell-mediated immunity (CMI), humoral immunity, passive, immunity, T-lymphocyte (T-cell). September 2010 2

3. Vaccine Development and Evaluation Integrates into practice knowledge about the main steps in vaccine development and evaluation. 1. Describe, in general terms, the process to obtain marketing approval for vaccines in Canada. 2. Describe what can be learned about vaccines after they are approved for marketing, via surveillance activities and more formal post marketing studies. 3. Characterize, in broad terms, the key roles and responsibilities for various stakeholders in post-marketing assessment of vaccine safety and effectiveness. Effectiveness, efficacy, immunogenic, post marketing surveillance, product monograph. September 2010 3

4. Immunizing Agents Applies the knowledge of the components and properties of immunizing agents as needed for safe and effective practice. 1. Classify each immunizing agent used in practice as live attenuated or inactivated/subunit, and compare the major advantages and disadvantages of live versus inactivated /subunit vaccines. 2. Identify key differences in the immune response to purified polysaccharide versus polysaccharide protein conjugate vaccines. 3. Describe live attenuated, inactivated and subunit immunizing agents to an audience with minimal or no science knowledge. 4. Describe, in general terms, the purpose, action and potential concerns of each of the following components that may be present in a given immunizing agent: adjuvant, preservative, additives 5. Locate and utilize current information resources on the types and content of immunizing agents used in practice. 6. Locate and utilize current information resources on addressing public concerns regarding immunizing agent components. Passive immunizing agent, active immunizing agent, additive, adjuvant, combination vaccine, inactivated vaccine, live attenuated vaccine, polysaccharide, preservative, protein conjugate, purified protein, subunit vaccine, toxoid.. September 2010 4

5. Vaccine Immune Response Explains how vaccines work using basic knowledge of the immune system. 1. Differentiate between the primary and memory immune response to a vaccine. 2. Explain why some vaccines induce a memory response while others do not. 3. Name some host and vaccine-related factors that affect the immune response to vaccines. 4. Respond to the concern that giving too many vaccines will overload the immune system. 5. Discuss the pros and cons of immunity gained through immunization as opposed to wild type infection. 6. Identify the key differences in the immune response to purified polysaccharide versus polysaccharide protein conjugate vaccines. Active immunity, antibody, antigen, B-lymphocyte (B-cell),booster, cellmediated immunity (CMI), humoral immunity, memory response, passive, immunity, primary immune response, protective levels, T-lymphocyte (Tcell). September 2010 5

6. Immunization Schedules Demonstrate an understanding of immunization schedules. 1. Describe the guidelines for immunization schedules. 2. Name the B.C. resources that are used to guide immunization schedules and decision making 3. Locate the current B.C. immunization schedules 4. Explain how the guidelines for immunization schedules accommodates factors that affect the immune response to vaccines 5. Illustrate in tabular format the vaccine, age, dose, route, site, contraindication, precaution, side effects for each vaccine. 6. Describe the unique immunization needs of individuals who are off course for recommended immunizations. BCCDC Immunization Program September 2010 6

7. Populations Requiring Special Considerations Recognizes and responds to the unique immunization needs of certain population groups. 1. Describe the unique immunization needs of certain populations including: Immunocompromised individuals Pregnant and breastfeeding women Occupational risk groups Individuals new to Canada 2. Appropriately refer to expert professional resources when required to address the immunization needs of certain populations. Special populations, occupational risk groups, new Canadians, immunocompromised, and pregnancy. September 2010 7

8. Storage and Handling of Immunizing Agents Implements provincial guidelines when storing, handling or transporting immunizing agents. 1. State where to access the most recent provincial guidelines dealing with immunizing agent storage, handling and transportation. 2. Describe the provincial guideline requirements for immunizing agent storage, handling and transportation. 3. Explain the importance of maintaining the cold chain. 4. Outline the key steps for maintaining the cold chain in the practice setting. 5. Explain actions taken to report and manage cold chain incidents that compromise immunizing agent integrity. Min-max thermometers, stock rotation, cold chain. September 2010 8

9. Administration of Immunizing Agents Prepares and administers immunizing agents correctly. 1. Name the resources that are used to guide immunization administration process and decision making. 2. Describe actions taken to increase safety in immunization clinics related to the provider, the recipient and the environment. 3. Ensure the 7 Rights of immunization: right drug, right client, right dose, right time, right route, right reason and right documentation. 4. Describe the steps involved in immunizing agent preparation, including reconstitution if appropriate, administration and disposal. 5. Choose the correct needle length and gauge for the age and size of the client. 6. Describe the age appropriate injection sites and proper client positioning used for immunization. 7. Describe techniques to reduce the pain associated with immunization. 8. Demonstrate the appropriate technique for immunization. Canadian Immunization Guide (CIG), contraindications, expiry date, injection error, injection site, needle length and gauge, needle stick injury, precautions, reconstitution, route of administration (intramuscular, subcutaneous, intradermal). September 2010 9

10. Reactions Following Immunization Anticipates, identifies and manages reactions following immunization. 1. Use reliable evidence-based resources to list the frequencies of the common, uncommon and rare adverse events associated with immunizing agents. 2. Inform recipients and/or their caregivers on what to expect and what to do regarding adverse events that could follow immunizations. 3. Describe the step-by-step response to anaphylaxis as appropriate to the immunization setting. 4. Locate appropriate forms and understand the process for submitting a report on an adverse event following immunization 5. Distinguish between reporting an adverse event following immunization and proving that immunization caused an adverse event. Adverse Event Following Immunization, anaphylaxis, causality, local reaction September 2010 10

11. Documentation Documents information relevant to each immunization encounter in accordance with provincial guidelines for immunization practices and jurisdictional health information processes. 1. Describe the role and importance of immunization records. 2. Identify the information to be documented on an immunization record 3. Record the reason for and planned follow-up action when a scheduled immunization is not given. Immunization Record (include both take-home and professional chart), lot number, and other minimal terms for recording. September 2010 11

12. Legal and Ethical Aspects of Immunization Acts in accordance with legal and high ethical standards. 1. Discuss the implications of the individual s right, confidentiality, privacy, informed consent and informed refusal. 2. Describe the legislations that impact immunization practice in BC. 3. Identify their professional scope of practice as it relates to immunization. 4. Discuss the issues arising from mandatory versus voluntary immunization. Informed consent, legislation, mandatory immunization, voluntary immunization. September 2010 12

13. Population Health Applies relevant principles of population health for improving immunization rates. 1. Use specific examples to show how immunization is a population-based health strategy. 2. Explain the concept of herd immunity (also called community immunity) in non scientific terms. 3. Explain, using examples, why vaccine-preventable diseases return when immunization coverage decreases. 4. Explain how immunization registries can benefit not only individuals but also populations. 5. Present the case for the importance of having a highly immunized healthcare work force. 6. Identify barriers (economic, educational and social factors) to immunization uptake. Community immunity, coverage, endemic, epidemic, epidemiology, epidemiological triangle, herd immunity, incidence, morbidity, mortality, pandemic. September 2010 13

14. Communication: Part 1 - Principles Communicates effectively about immunizations. 1. Explain the importance of risk perception for immunization decision making. 2. Respond appropriately following an assessment of client knowledge, attitudes, and beliefs regarding immunization. 3. Deliver clear, concise messages about the risks of vaccine-preventable diseases and the benefits/risks of vaccines. 4. Provide guidance to clients so they can correctly identify credible sources of information on immunization and vaccines. Credible sources, informed decision making, risk communication, risk perception. September 2010 14

15. Communication: Part 2 - Immunization Issues Addresses immunization issues using an evidenced based approach. 1. Address misperceptions regarding immunizing agents using evidence based approach. 2. Locate evidenced based sources of information on current issues relating to immunization. 3. Use scientific knowledge to develop clear, concise key messages regarding true immunization benefits and risks. September 2010 15

16. The Canadian Immunization System Demonstrate an understanding of the immunization system in Canada and its impact on his/her own practice. 1. Describe how the National Immunization Strategy (NIS) is relevant to practice. 2. Distinguish between federal and provincial/territorial responsibilities as related to immunization programs in Canada. 3. Explain the reasons for the variable immunization schedules among the provinces and territories. 4. List who can administer immunizations in British Columbia. September 2010 16